Exogenous platelet-activating factor stimulates cell proliferation in mouse pre-implantation embryos prior to the fourth cell cycle and shows isoform-specific stimulatory effects

Zygote

Volumn 9, Issue 3, 2001, Pages 261-268

  Stoddart, Neil R ^a,d   Roudebush, William E ^b   Fleming, Steven D ^c  

^a NOTTINGHAM UNIVERSITY HOSPITALS NHS TRUST   (United Kingdom)

^b MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^c UNIVERSITY OF SYDNEY   (Australia)

^d University Community Hospital Tampa   (United States)

Author keywords

Cell proliferation; Embryo; Isoform; Mouse; PAF

Indexed keywords

ISOPROTEIN; THROMBOCYTE ACTIVATING FACTOR;

ANIMAL; ARTICLE; BLASTOCYST; CELL CYCLE; CELL DIVISION; CHEMISTRY; DOSE RESPONSE; FEMALE; METABOLISM; MORULA; MOUSE; PHYSIOLOGY; PROTEIN BINDING; TIME; ZYGOTE;

ANIMALS; BLASTOCYST; CELL CYCLE; CELL DIVISION; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; MICE; MORULA; PLATELET ACTIVATING FACTOR; PROTEIN BINDING; PROTEIN ISOFORMS; TIME FACTORS; ZYGOTE;

EID: 0035430698     PISSN: 09671994     EISSN: None     Source Type: Journal    
DOI: 10.1017/S0967199401001289     Document Type: Article

References (33)

1. Adamson, L.M., Podsiadly, B., Smart, Y.C., Stanger, J.D. & Roberts, T.K. (1991). Studies on murine embryo-derived platelet-activating factor. Mol. Reprod. Dev. 30, 207-13.
2. Ammit, A.J., Wells, X.E. & O'Neill, C. (1992). Structural heterogeneity of platelet-activating factor produced by murine preimplantation embryos. Hum. Reprod. 6, 865-70.
3. Bitoh, H. & Shimizu, T. (1997). Molecular characterisation and physiological functions of PAF receptors. Adv. Exp. Med. Biol. 400, 215-21.
4. Blank, M.L., Cress, E.A., Lee, T.-C., Malone, B., Surles, J.R., Piantadoshi, C., Hajdu, J. & Snyder, F. (1982). Structural features of platelet-activating factor (1-alkyl-2-acetyl-sn-3-phosphocholine) required for hypotensive and platelet serotonin release. Res. Commun. Chem. Pathol. Pharmacol. 38, 3-20.
5. Chao, W. & Ohlson, M.S. (1993). Platelet-activating factor: receptors and signal transduction. Biochem. J. 292, 617-29.
6. Curtin, M.L. (1998). Current status of platelet-activating factor antagonists. Expert Opin. Ther. Patents 8, 703-11.
7. Demopoulos, C.A., Pinckard, R.N. & Hanahan, D.J. (1979). Platelet-activating factor: evidence for a 1-O-alkyl-sn-glyceryl-3-phosphorylcholine as the active component. J. Biol. Chem. 254, 9355-8.
8. Hanahan, D.J. (1986). Platelet-activating factor: a biologically active phosphoglyceride. Annu. Rev. Biochem. 55, 483-509.
9. Honda, Z.-I., Nakamura, M., Miki, I., Minami, M., Watanabe, T., Seyama, Y., Okado, H., Toh, H., Ito, K.l, Miyamoto, T. & Shimizu, T. (1991). Cloning by functional expression of platelet-activating factor receptor from guinea-pig lung. Nature 349, 342-6.
10. Hwang, S.-B. & Lam, M.-H. (1986). Species differences in the specific receptors of Platelet-Activating Factor. Biochem. Pharmacol. 35, 4511-18.
11. Kudolo, G.B. & Harper, M.J.K. (1989). Characterisation of platelet-activating factor binding sites on uterine membranes from pregnant rabbits. Biol. Reprod. 41, 587-607.
12. Kunz, D., Gerard, N.P. & Gerard, C. (1992). The human leukocyte platelet-activating factor receptor cDNA: cloning, cell surface expression and construction of a novel epitope-bearing analogue. J. Biol. Chem. 267, 9101-6.
13. Lambrecht, G. & Pamham, M.J. (1986). Kadsurenone distinguishes between different Platelet-Activating Factor receptor subtypes on macrophages and polymorphonuclear leukocytes. Br. J. Pharmacol. 87, 287-9.
14. Minhas, B.S. (1991). Platelet-activating factor promotes mouse embryonic growth in vitro. ARTA II, 321-4.
15. Minhas, B.S., Ripps, B.A., Zhu, Y.P., Kim, H.N., Burwinkel, T.H. & Gleicher, N. (1996). Platelet-activating factor and conception. Am. J. Reprod. Immunol. 35, 267-71.
16. Nakamura, M., Hondo, Z.-I., Izumi, T., Sakanaka, C., Mutoh, H., Minami, M., Bito, H., Seyama, Y., Matsumoto, T., Noma, M. & Shimizu, T. (1991). Molecular cloning and expression of platelet-activating factor receptor from human leukocytes. J. Biol. Chem. 266, 20400-5.
17. O'Neill, C. (1991). A consideration of the factors which influence and control the viability and developmental potential of the preimplantation embryo. Baillieres Clin. Obstet. Gynaecol. 5, 159-78.
18. O'Neill, C. (1997). Platelet-activating factor promotes the development of the preimplantation embryo. Adv. Exp. Med. Biol. 416, 255-61.
19. O'Neill, C. (1998). Autocrine mediators are required to act on the embryo by the 2-cell stage to promote normal development and survival of mouse preimplantation embryos in vitro. Biol. Reprod. 58, 1303-9.
20. O'Neill, C., Collier, M., Ammit, A.J., Ryan, J.P., Saunders, D.M. & Pike, I.L. (1989). Supplementation of in vitro fertilisation culture medium with platelet-activating factor. Lancet II, 769-72.
21. O'Neill, C., Ryan, J.P., Collier, M., Saunders, D.M., Ammit, A.J. & Pike, I.L. (1992). The outcome of pregnancies resulting from a trial of supplementing human IVF media with platelet-activating factor. Reprod. Fertil. Dev. 4, 109-12.
22. Roberts, C., O'Neill, C. & Wright, L. (1993). Platelet-activating factor (PAF) enhances mitosis in preimplantation mouse embryos. Reprod. Fertil. Dev. 5, 271-9.
23. Roudebush, W.E., Mathur, S. & Butler, W.J. (1995). Antiplatelet-activating factor (PAF) antibody inhibits CFW mouse preimplantation embryo development. J. Assist. Reprod. Genet. 11, 414-18.
24. Roudebush, W.E., Duralia, D.R. & Butler, W.J. (1996). Effect of platelet-activating factor (PAF) on preimplantation mouse B6D2F1/J embryo formation. Am. J. Reprod. Immunol. 35, 272-6.
25. Roudebush, W.E., LaMarche, M., Levine, A.S., Jiang, H. & Butler, W.J. (1997). Evidence for the presence of the platelet-activating factor receptor in the CFW mouse preimplantation two-cell stage embryo. Biol. Reprod. 57, 575-9.
26. Ryan, J.P., Spinks, N.R., O'Neill, C., Ammit, A.J. & Wales, R.G. (1989). Platelet-activating factor (PAF) production by mouse embryos in vitro and its effect on embryonic metabolism. J. Cell. Biochem. 40, 387-95.
27. Ryan, J.P., O'Neill, C. & Wales, R.G. (1990a). Oxidative metabolism of energy substrates by preimplantation mouse embryos in the presence of platelet-activating factor. J. Reprod. Fertil. 89, 301-7.
28. Ryan, J.P., Spinks, N.R., O'Neill, C. & Wales, R.G. (1990b). Implantation potential and foetal viability of mouse embryos cultured in media supplemented with platelet-activating factor. J. Reprod. Fertil. 89, 309-15.
29. Spinks, N.R. & O'Neill, C. (1988). Antagonists of embryo-derived platelet-activating factor prevent implantation of mouse embryos. J. Reprod. Fertil. 84, 89-98.
30. Spinks, N.R., Ryan, J.P. & O'Neill, C. (1990). Antagonists of embryo-derived platelet-activating factor act by inhibiting the ability of the mouse embryo to implant. J. Reprod. Fertil. 88, 241-8.
31. Stoddart, N.R., Wild, A.E. & Fleming, T.P. (1996). Stimulation of development in vitro by platelet-activating factor receptor ligands released by mouse preimplantation embryos. J. Reprod. Fertil. 108, 47-53.
32. Stojanov, T. & O'Neill, C. (1999). Ontogeny of expression of a receptor for platelet-activating factor in mouse pre-implantation embryos and the effects of fertilization and culture in vitro on its expression. Biol. Reprod. 60, 674-82.
33. Ye, R.D., Prossnitz, E.R., Zou, A.M. & Cochrane, C.G. (1991). Characterization of a human cDNA that encodes a functional receptor for platelet-activating factor. Biochem. Biophys. Res. Commun. 180, 105-11.